Publicacions en què col·labora amb Eduard Vieta i Pascual (8)

2018

  1. Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: Protocol for a phase IV, single-arm, open-label trial

    BMJ Open, Vol. 8, Núm. 10

2015

  1. Disability in bipolar i disorder: The 36-item World Health Organization Disability Assessment Schedule 2.0

    Journal of Affective Disorders, Vol. 174, pp. 353-360

2013

  1. The screen for cognitive impairment in psychiatry: Diagnostic-specific standardization in psychiatric ill patients

    BMC Psychiatry, Vol. 13

2012

  1. Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia

    Schizophrenia Research, Vol. 138, Núm. 2-3, pp. 240-247

2011

  1. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP)

    Schizophrenia Research, Vol. 130, Núm. 1-3, pp. 137-142

2010

  1. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)

    Schizophrenia Research, Vol. 116, Núm. 2-3, pp. 243-251

2009

  1. Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder

    Health and Quality of Life Outcomes, Vol. 7

2008

  1. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia

    Schizophrenia Research, Vol. 99, Núm. 1-3, pp. 139-148